NEW YORK (GenomeWeb News) - Accelrys and Agilent Technologies said yesterday that they have struck an agreement to resell each other's software to pharmaceutical companies through an integration and licensing agreement.
Under the agreement, Accelrys will resell Agilent's OpenLAB enterprise content manager, Kalabie electronic lab notebook, and GeneSpring gene expression software. Agilent will resell Accelrys' Accord cheminformatics solutions and Pipeline Pilot scientific operating platform.
"Agilent's strength in laboratory Informatics, QA/QC, and manufacturing are a natural complement to Accelrys' expertise in research, early development, and scientific data management," said Accelrys CEO Mark Emkjer.
Agilent's vice president and general manager, Bruce von Herrmann, said the integrated license and joint resale deal will benefit pharmaceutical clients "that want to spend less time integrating existing informatics solutions and more time developing new, more effective medicines."
Financial terms of the agreement were not released.